Mostrando 81 - 100 Resultados de 2,608 Para Buscar '"CHF"', tiempo de consulta: 0.49s Limitar resultados
  1. 81
    “…INTRODUCTION: Chronic heart failure (CHF) is a life-threatening chronic disease characterised by periodic exacerbations and recurrent hospitalisations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Innovative Telemonitoring Enhanced Care Programme for Chronic Heart Failure (ITEC-CHF) to improve guideline compliance and collaborative care: protocol of a multicentre randomised controlled trial
  2. 82
    “…OBJECTIVE: CHF5633 (Chiesi Farmaceutici S.p.A., Parma, Italy) is the first fully synthetic surfactant enriched by peptide analogues of two human surfactant proteins. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome
  3. 83
    “…Methods and Results: The J-CHF study was a prospective randomized multicenter trial that assigned 360 HFrEF patients to a 2.5 mg/5 mg/20 mg target dose of carvedilol. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Differential Response to Heart Rate Reduction by Carvedilol in Heart Failure and Reduced Ejection Fraction Between Sinus Rhythm and Atrial Fibrillation　― Insight From J-CHF Study ―
  4. 84
    “…Chronic heart failure (CHF) is a key part of cardiovascular continuum. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms
  5. 85
    “…BACKGROUND: The role of endothelin-1 (ET-1) in the neurobiology of anxiety is unknown, therefore, we assessed in the observational multicenter DIAST-CHF study whether the C-terminal ET-1 precursor fragment (CT-proET-1) is linked to anxiety. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
  6. 86
    “…BACKGROUND: There is a notable inequity in access to palliative care (PC) services between cancer and Chronic Heart Failure (CHF)/Chronic Obstructive Pulmonary Disease (COPD) patients which also translates into discrepancies in the level of integration of PC. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Is the content of guidelines/pathways a barrier for the integration of palliative Care in Chronic Heart Failure (CHF) and chronic pulmonary obstructive disease (COPD)? A comparison with the case of cancer in Europe
  7. 87
    por Anderson, Evan J, Hussaini, Laila, Bristow, Laurel, Tippett, Ashley, Gibson, Theda, Hart, Mari, Salazar, Luis, Gaffney, Michelle, Benyeogor, Ifeyinwa Kanayo, Cheng, Andrew, Drobeniuc, Ana, Traenkner, Jessica, Fayad, Danielle, Washington, Wesley, Emerson, Lisa, Schwartz, Natalia, Greaves, Kandra, Todd, Sean, Stanley, Corshé, Bechnak, Amer, Chaaya, Rody Bou, Al-Husien, Zayna, Deović, Rijalda, Winston, Juton, Ahmed, Dilshad Rafi, Li, Wensheng, Le, Khuong, Singh, Aditya, Spencer, Jennifer E, Muchinsky, Amy, Zaks, Kathryn, Nesheim, Wendy, Stephens, Kathy, Swerdlow, David L, Hubler, Robin, Agosti, Yasmeen, Munye, Mohamed, Jadhao, Samadhan, Ha, Binh, McCracken, Courtney, Kraft, Colleen, Rostad, Christina A, Kao, Carol, Lopman, Ben, Yildirim, Inci, Anderson, Larry, Rouphael, Nadine, Rouphael, Nadine
    Publicado 2019
    “…BACKGROUND: Data are limited about the burden of respiratory syncytial virus (RSV)-related hospitalizations in older adults and those with COPD or CHF. METHODS: We conducted prospective surveillance at two hospitals from October 2018 to March 2019 for adults ≥50 years of age admitted with acute respiratory infections (ARI) and adults of any age with COPD or CHF-related admissions. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2314. Burden of Respiratory Syncytial Virus (RSV) Infection Among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
  8. 88
    “…Background: The aim of the prospective post-marketing AF-CHF Landiolol Survey was to evaluate the safety and effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter in patients with cardiac dysfunction in clinical practice in Japan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure　― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―
  9. 89
    “…RESULTS: RSV was detected in 71/2,728 (2.6%) hospitalized adults with ARI, CHF, or COPD and 4/466 (0.9%) controls. In Season 1, RSV occurred in 5.9% (35/596 patients), in Season 2 3.6% (35/970 patients), but in only 0.09% (1/1,162 patients) in Season 3 (P < 0.001 for both seasons). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1329. Burden of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
  10. 90
    por Chan, C.H.F., Stanners, C.P.
    Publicado 2007
    Enlace del recurso
    Enlace del recurso
    Texto
    Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
  11. 91
    “…METHODS: Over the course of 3 consecutive winter respiratory viral seasons, adults ≥ 50 years of age admitted with acute respiratory tract infections (ARI) and adults of any age with COPD or CHF-related admissions were enrolled from 2 Atlanta area hospitals. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1334. Outcomes Among Influenza and SARS-CoV-2 Infection in Hospitalized Adults Age ≥ 50 Years and with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
  12. 92
    “…Majority (92.7%) of participants consented to participate, with 229 (49.8%) and 231 (50.2%) members and non members of CHF/TIKA respectively. Majority (90.9%) were aware of CHF/TIKA. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Barriers and facilitators to enrollment and re-enrollment into the community health funds/Tiba Kwa Kadi (CHF/TIKA) in Tanzania: a cross-sectional inquiry on the effects of socio-demographic factors and social marketing strategies
  13. 93
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mono- and Mixed Metal Complexes of Eu(3+), Gd(3+), and Tb(3+) with a Diketone, Bearing Pyrazole Moiety and CHF(2)-Group: Structure, Color Tuning, and Kinetics of Energy Transfer between Lanthanide Ions
  14. 94
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial
  15. 95
    “…In this paper, we report the anisochrony of the fluorine atoms of a CHF(2) group when linked to a pyrazole ring. The pyrazole is part of (4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-2H-indazole also known as (4S,7R)-campho[2,3-c]pyrazole, which has two stereogenic centers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    (19)F-NMR Diastereotopic Signals in Two N-CHF(2) Derivatives of (4S,7R)-7,8,8-Trimethyl-4,5,6,7-tetrahydro-4,7-methano-2H-indazole †
  16. 96
    por Wong, C.H.F., Chau, H., Man, C.W., Chu, S.K.
    Publicado 2019
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Case of nephropulmonary fistula and literature review
  17. 97
    “…This paper proposes the use of environmentally friendly alternatives, C(6)F(6) and C(4)H(2)F(6), as perfluorocarbon (PFC) and hydrofluorocarbon (HFC) precursors, respectively, for SiO(2) plasma etching, instead of conventional precursors C(4)F(8) and CHF(3). The study employs scanning electron microscopy for etch profile analysis and quadrupole mass spectrometry for plasma diagnosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Characterization of SiO(2) Plasma Etching with Perfluorocarbon (C(4)F(8) and C(6)F(6)) and Hydrofluorocarbon (CHF(3) and C(4)H(2)F(6)) Precursors for the Greenhouse Gas Emissions Reduction
  18. 98
    Publicado 2009
    Enlace del recurso
    Enlace del recurso
    Texto
    Stochastic Simulations of Clusters: Quantum Methods in Flat and Curved Spaces. By Emanuele Curotto, CRC Press, 2010; 696 pages, Hard Cover. Price: $159.95/CHF 257.00 ISBN 978-1-4200-8225-8
  19. 99
    “…METHODS AND ANALYSIS: To assess the effect of SGLT2 inhibitors when used in combination with a loop diuretic, the RECEDE-CHF (Renal and Cardiovascular Effects of SGLT2 inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure) trial is a single-centre, randomised, double-blind, placebo-controlled, cross-over trial conducted in a secondary care setting within NHS Tayside, Scotland. 34 eligible participants, aged between 18 and 80 years, with stable T2D and CHF will be recruited. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
  20. 100
    “…Eligible patients will be randomly assigned in a 1:1 manner to receive thyroxine replacement therapy plus standard chronic heart failure (CHF) treatment or only standard CHF therapy. Levothyroxine will be administered at an initial dose of 12.5 μg once daily and will be titrated until TSH is within the normal range. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF)
Herramientas de búsqueda: RSS